In 7 out of 60 WD patients under therapy, disease progression was evidenced by liver biopsies, yet no significant differences on biochemical parameters (ALT, Cp, serum copper, and UCE) and intrahepatic copper quantification were observed [50]. The gene discussed is GPT; the disease is Wilson disease.